Engineering CELLS,
   Engineering RESPONSES


  • BTI Event
Date: Tue. 2 Oct, 2018 15:00 PM
Venue: BTI Board Room, Level 6, Centros, 20 Biopolis Way, Singapore 138668

Dr Poh Weijie
Cofounder, PathoVax LLC


In 2014, Weijie cofounded PathoVax, a Johns Hopkins spinoff, to further develop a breakthrough vaccine that blocks all human papillomavirus (HPVs) associated with cervical cancer. In this talk, he will share his journey in moving this technology out of the lab into clinical trials, that includes working with contract manufacturing organizations on scale-up production, regulators on formulation work and clinicians on defining the clinical opportunity.


    Biopolis Event        BTI Event        External Event